Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
OneSpaWorld Q2 2025 Earnings Call - Strong Onboard Spend, MediSpa Growth and AI Lift Adjusted EBITDA Guidance
OneSpaWorld reported a clean beat in Q2 2025, with revenue up 7% to $240.7 million and adjusted EBITDA rising 13% to $30.5 million. Management affirmed full-year revenue guidance, and raised the midpo...
- Total revenue increased 7% year over year to $240.7 million in Q2 2025.
- Adjusted EBITDA rose 13% to a record $30.5 million, and income from operations climbed 17% to $22.1 million.
- Net income grew 27% to $19.9 million, or $0.19 diluted EPS, helped by lower interest expense and higher operating income.
- +13 more takeaways
STAG Industrial Q2 2025 Earnings Call - Robust Leasing Spreads and Moody's Baa2 Upgrade Support Growth
STAG reported a steady quarter: core FFO per share of $0.63, healthy leasing velocity, and better-than-expected operating fundamentals that allowed management to nudge guidance higher. Leasing remains...
- Core FFO per share was $0.63 in Q2 2025, up 3.3% year over year.
- STAG commenced 32 leases totaling 4.2 million square feet in Q2, generating cash leasing spreads of 24.6% and straight-line spreads of 41.1%.
- Of the 4.2 million square feet leased in the quarter, 1.6 million square feet was new leasing; retention for the quarter was 75.3%.
- +15 more takeaways
Chemed Corporation Second Quarter 2025 Earnings Call - Florida Medicare Cap Drives $28.2M Hit and Lowers EPS Guidance
Chemed reported a tough Q2 driven by a Medicare cap shortfall in Florida that forced a meaningful charge and a material pullback in full-year guidance. VITAS saw modest volume growth but a patient-mix...
- Chemed accrued $16.4 million of Medicare cap billing limitations in Q2 2025; it estimates total calendar 2025 Medicare cap limitations of $28.2 million, comprised of $19.0 million for the combined Florida program and $9.2 million for all other VITAS programs.
- The $16.4 million Q2 accrual breaks down into a $9.5 million catch-up entry related to the first six months of the cap year, $4.8 million for the current Florida cap period, and $2.1 million for other programs (mainly California).
- VITAS admissions totaled 17,545 in Q2 2025, a 1.2% increase versus Q2 2024; excluding Covenant Health transfers from the April 2024 acquisition, admissions rose 4.9%.
- +9 more takeaways
Wingstop Inc. Fiscal Second Quarter 2025 Earnings Call - Smart Kitchen Cuts Times, Sparks Record Openings and a Clear Path Toward $3M AUV
Wingstop reported a quarter of heavy execution and selective stress. System‑wide sales rose 13.9% to $1.3 billion while domestic same‑store sales fell 1.9% against very tough compares. The standout wa...
- System‑wide sales grew 13.9% to $1.3 billion in Q2; domestic same‑store sales declined 1.9% versus lapping 28.7% comp in 2024 and 16.8% in 2023.
- Wingstop opened a record 129 net new restaurants in Q2, the highest single‑quarter openings in company history; 255 net new units have opened through 2025 YTD.
- Company raised 2025 global unit growth guidance to 17%–18%, implying 435 to 460 net new restaurants for the full year.
- +14 more takeaways
Kadant Inc. Second Quarter 2025 Earnings Call - Aftermarket Parts Prop Up Margins While Tariffs Cloud Capital Timing
Kadant reported a mixed quarter: strong aftermarket parts demand drove record consumables revenue and lifted gross margins, while capital shipments lagged versus last year, leaving revenue down and ea...
- Bookings rose 7% in Q2 to $269 million, driven by capital orders and stable aftermarket demand.
- Revenue fell 7% year over year to $255.3 million, held back by fewer capital shipments versus a record Q2 2024.
- Record aftermarket parts and consumables revenue was $181.8 million, representing 71% of total revenue in 2Q25.
- +16 more takeaways
Gates Industrial Corporation Q2 2025 Earnings Call - FX-Driven Guidance Lift, Data Center and Personal Mobility Poised to Drive Growth
Gates reported a steady quarter: revenue roughly flat on a core basis, adjusted EBITDA of $199M and EPS of $0.39, while raising full year EBITDA and EPS guidance after favorable foreign exchange trans...
- Total Q2 sales $884.0M, core revenue down 0.6% year over year; underlying demand largely as expected.
- Adjusted EBITDA $199.0M, margin 22.5%, a 30 basis point decline year over year; comparability hurt by a $7M prior-year real estate gain that represented ~80 bps of margin.
- Gross margin 40.8%, the fifth consecutive quarter above 40%; gross margin expanded 40 basis points in the quarter.
- +12 more takeaways
Silgan Holdings Q2 2025 Earnings Call - Dispensing and Pet Food Drive Record EBIT, But Weather and a Customer Bankruptcy Trim 2025 Outlook
Silgan reported a strong second quarter, driven by high-margin dispensing products and accelerating pet food demand, with record adjusted EBIT and 15% adjusted EPS growth. The Vayner acquisition is in...
- Q2 headline results: net sales ~ $1.5 billion, adjusted EBIT $193 million (record), adjusted EPS $1.01, adjusted EPS up 15% year over year.
- Dispensing and Specialty Closures led growth, with segment sales up 24% year over year, record segment adjusted EBIT, and over 40% growth in dispensing products versus prior year.
- Vayner acquisition integration is proceeding well culturally and commercially, contributing materially to dispensing growth and creating additional commercial opportunities beyond original synergy estimates.
- +12 more takeaways
First Interstate BancSystem Inc. Second Quarter 2025 Earnings Call - Balance sheet remix boosts capital and sets path to margin recovery despite near-term loan runoff
First Interstate reported a clean quarter on the surface, with net income of $71.7 million, EPS $0.69, and NII of $207.2 million while management accelerates a deliberate balance sheet remix. The bank...
- Net income $71.7 million, diluted EPS $0.69 in Q2 2025, up from $50.2 million and $0.49 in Q1.
- Net interest income $207.2 million, NIM 3.32% FTE; excluding purchase accounting accretion NIM was 3.26%, up 12 bps quarter over quarter.
- Management continues strategic pruning: stopped new originations in indirect lending earlier, outsourced consumer credit card loans, and moved Arizona and Kansas loans ($338 million) to held for sale ahead of a Q4 branch sale.
- +12 more takeaways
Kura Sushi USA Inc. Fiscal Third Quarter 2025 Earnings Call - Reservation Rollout, Record IP Pipeline Position Chain for FY26 Recovery
Kura Sushi reported a mixed quarter but one full of operational momentum. Q3 sales were $74.0 million, comparable sales declined 2.1% as traffic fell 2.9% while pricing and mix contributed +0.8%. Mana...
- Total Q3 sales $74.0 million, comparable restaurant sales -2.1%, traffic -2.9% and price and mix +0.8%.
- Effective price in the quarter was reported at 4.3%; a 1% menu increase on June 1 was noted and effective pricing for Q4 is expected at 3.5%.
- COGS improved to 28.3% of sales, down 90 basis points year over year, credited to pricing and supply chain work. Tariff risk remains, management believes they can stay below roughly 30% COGS even in a downside scenario, and suppliers may absorb some impact.
- +11 more takeaways
Ionis Pharmaceuticals Second Quarter 2025 Earnings Call - Trengolza Launch Accelerates, Donidalorsen PDUFA Aug 21, SHTG Readouts Set for September
Ionis used this quarter to prove it can launch, raise guidance, and keep a packed late-stage pipeline moving toward commercial inflection points. Trengolza’s early commercial performance exceeded expe...
- Trengolza Q2 net product sales were $19 million, a threefold increase versus Q1, and the launch is described as early innings but exceeding expectations.
- Coverage and access for Trengolza are favorable: roughly 60% commercial and 40% government coverage, with over 90% of patients paying $0 out of pocket to date.
- Ionis’ patient support effort is working: the Ionis Every Step Support Program has near-universal opt-in and the commercial team has engaged over 3,000 physicians and targeted more than 30,000 HCPs.
- +13 more takeaways